Skip to main content
logo
Botanix Pharmaceuticals Limited (ASX:BOT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0200
+0.0010 (5.26%)
Sep 11, 2026, 12:04 PM AEST

Botanix Pharmaceuticals Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Revenue
33.85.792.073.772.75
Revenue
33.85.792.073.772.75
Revenue Growth
483.87%179.74%-45.14%36.94%-60.00%
Cost of Revenue
14.353.773.655.7310.29
Gross Profit
19.452.02-1.58-1.96-7.54
Selling, General & Admin
76.0462.157.944.414.28
Other Operating Expenses
---1.130.89
Operating Expenses
88.7684.9312.417.175.65
Operating Income
-69.31-82.91-13.99-9.13-13.19
Interest Expense
-2.84-5.37-0.01-0.08-0.04
Interest & Investment Income
1.111.880.080.070.04
Currency Exchange Gain (Loss)
-0.320.010.06-0.010.02
Other Non Operating Income (Expenses)
1.59----
Pretax Income
-69.77-86.4-13.87-9.15-13.17
Net Income
-69.77-86.4-13.87-9.15-13.17
Net Income to Common
-69.77-86.4-13.87-9.15-13.17
Net Income Growth
-----
Shares Outstanding (Basic)
2,1651,8451,5021,154973
Shares Outstanding (Diluted)
2,1651,8451,5021,154973
Shares Change
17.34%22.87%30.12%18.58%0.02%
EPS (Basic)
-0.03-0.05-0.01-0.01-0.01
EPS (Diluted)
-0.03-0.05-0.01-0.01-0.01
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-64.6-78.87-8.24-12.08-11.19
Free Cash Flow Per Share
-0.03-0.04-0.01-0.01-0.01
Gross Margin
57.55%34.85%-76.48%-51.83%-273.62%
Operating Margin
-205.05%-1432.24%-676.11%-241.93%-478.66%
Profit Margin
-206.41%-1492.37%-670.20%-242.66%-478.10%
Free Cash Flow Margin
-191.10%-1362.39%-398.17%-320.27%-406.24%
EBITDA
-66.99-80.65-13.92-9.11-13.17
EBITDA Margin
-198.20%---241.38%-
D&A For EBITDA
2.322.260.070.020.02
EBIT
-69.31-82.91-13.99-9.13-13.19
EBIT Margin
-205.05%---241.93%-
Revenue as Reported
----2.79